|
|
||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (J.S.C., K.S.S., S.T.K., J.W.K., C.J.S.), Surgery (S.M.N.), and Pathology (D.Y.K.), Chungnam University Hospital Daesa-dong 640, Joong-Ku, Taejon 301-040, Korea; the Department of Radiology, Sun General Hospital, Taejon, Korea (H.Y.K.); and the Department of Radiology, Chunnam University Hospital, Kwangju, Korea (H.K.K.). Received August 27, 1999; revision requested October 7; revision received January 19, 2000; accepted February 7. Address correspondence to J.S.C. (e-mail: jscho@cnuh.chungnam.ac.kr).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: CT findings in 12 patients with heterotopic pancreas in the stomach were reviewed. Surgical resection (n = 11) or endoscopic excision (n = 1) was performed in cases of symptomatic heterotopic pancreas (n = 4), suspected submucosal tumors (n = 7), and gastric carcinoma (n = 1). Seven patients underwent helical CT with water as an oral contrast agent; five underwent nonhelical CT with water-soluble contrast material.
RESULTS: Nine heterotopic pancreata were in the antrum and one each was in the body, fundus, and perigastric fat. Seven lesions were on the greater curvature aspect; five, on the lesser curvature aspect. Common CT findings were well-defined oval or round masses with smooth or serrated margins in the gastric antral wall. Four of the seven lesions in which helical CT was performed enhanced similarly to normal pancreas. Preoperatively, CT depicted 11 of the 12 lesions, but CT findings were interpreted correctly as heterotopic pancreas in only two; the remaining 10 were misinterpreted as other lesions. Atypical findings were cystic dilatation of heterotopic pancreatic duct in two, unusual location in the fundus or perigastric fat in two, and malignant transformation in one.
CONCLUSION: CT findings of heterotopic pancreas in the stomach appear to be nonspecific for diagnosis, except for location.
Index terms: Pancreas, heterotopic (new), 72.314 Stomach, abnormalities, 72.314 Stomach, CT, 72.1211 Stomach, neoplasms, 72.312
| INTRODUCTION |
|---|
|
|
|---|
The characteristic radiographic appearance of heterotopic pancreas in the stomach at upper gastrointestinal examination has been described as that of a small broad-based submucosal mass in the antrum, with a central umbilication that represents a rudimentary pancreatic duct; the mass resembles leiomyoma or other submucosal tumors such as carcinoid or intramural metastasis (48). The mass usually is located along the greater curvature of the stomach, often in the prepyloric area within 6 cm of the pyloric canal (38). On occasion, heterotopic pancreas appears as a mass with an irregular surface indistinguishable from an adenomatous polyp or a polypoid carcinoma (4,8). Therefore, the radiographic findings of heterotopic pancreas in the stomach may easily be misinterpreted as a gastric tumor. Although the characteristic radiographic findings of heterotopic pancreas in the stomach have been described in the literature (47), to our knowledge no investigators have described the computed tomographic (CT) findings of heterotopic pancreas in the English-language radiology literature. The purpose of this retrospective review of cases was to describe the CT findings of heterotopic pancreas in the stomach, with histopathologic correlation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Nine patients had epigastric pain, and one had melena. The remaining two patients had no symptoms. Ten patients with symptomatic lesions underwent CT for further evaluation of the extent of the lesion before confirmation of the endoscopic biopsy results. Four of these 10 patients with apparent symptomatic lesions received a diagnosis of heterotopic pancreas by means of endoscopic biopsy. The remaining six patients did not receive a diagnosis by means of endoscopic biopsy and were classified as having an indeterminate submucosal tumor. Nine of 10 patients symptomatic lesions were treated with surgical wedge resection, and one was treated with endoscopic excision. After the removal of the heterotopic pancreas, follow-up was performed in six patients, and symptoms were improved in all six. Of two patients with asymptomatic lesions, one patient had a lesion that was detected incidentally as a submucosal mass at endoscopic screening for the early detection of gastric carcinoma, and the patient underwent CT for further evaluation. The lesion was removed with wedge resection under an indeterminate submucosal tumor because endoscopic biopsy did not result in a diagnosis. The other patients lesion was detected incidentally at CT for gastric cancer staging as a nodular lesion in the perigastric fat of the gastric antrum.
CT Techniques
Seven of the 12 patients underwent dual-phase helical CT with a HiSpeed Advantage scanner (GE Medical Systems, Milwaukee, Wis). The remaining five patients underwent nonhelical CT with a model CT/T 9800 scanner (GE Medical Systems) or an Xpeed scanner (Toshiba Medical Systems, Tokyo, Japan) because a helical CT scanner was not available. To better depict gastric lesions, 6001,000 mL of water was administered as an oral contrast agent before dual-phase helical CT. A total of 150 mL of nonionic contrast material, 300 mg/mL of iodine (iopromide [Ultravist; Schering, Berlin, Germany]), was administered with a power injector (MCT Plus; Medrad, Pittsburgh, Pa) at a rate of 35 mL/sec for 3050 seconds. We used an 18-20-gauge intravenous catheter (Jelco; Ethicon SPA, Rome, Italy) for the intravenous injection of contrast material into the antecubital vein. In accordance with the CT protocol for gastric tumors at Chungnam University Hospital, we obtained dual-phase images during the portal and equilibrium phases. Dual-phase helical CT scans were obtained 60 seconds (portal phase) and 3 minutes (equilibrium phase) after the start of the intravenous administration of a bolus of contrast material. Helical CT was performed with a 1-second scanning time, a 1:1 pitch, 5- or 7-mm section thickness, and 5- or 7-mm reconstruction interval. The images were obtained from the right side of the diaphragmatic dome to the inferior margin of the liver. The portal phase images were obtained for improved lesion conspicuity and for improved depiction of small hepatic metastases and lymphadenopathy. The equilibrium phase images were obtained to evaluate tumor extent with delayed enhancement of the tumors.
Nonhelical CT was performed with a continuous 5- or 10-mm section thickness and 5- or 10-mm intervals. Before nonhelical CT, 600800 mL of water-soluble oral contrast material (2% meglumine amidotrizoate solution [Gastrografin; Schering, Berlin, Germany) was administered. A total of 100120 mL of nonionic contrast material (300 mg of iodine per milliliter) was administered intravenously.
Image Analysis
The CT findings in 12 patients with heterotopic pancreas in the stomach were interpreted prospectively by two abdominal radiologists (J.S.C. and K.S.S.) without prior knowledge of the upper gastrointestinal study or endoscopic biopsy findings. When there was disagreement in CT readings, the final decision was made with a consensus of the two investigators. The size, location, and contrast material enhancement patterns of the lesions on the CT scans were analyzed. The lesions were measured by using an electronic caliper at the workstation or operator console. The degree of contrast material enhancement of the lesions on the helical CT scans was qualitatively analyzed relative to normal pancreatic enhancement. The CT images were compared retrospectively with the surgical and histopathologic findings to better characterize the CT findings of heterotopic pancreas.
| RESULTS |
|---|
|
|
|---|
The findings at upper gastrointestinal examination in 12 patients were interpreted as heterotopic pancreas in three, submucosal tumor in seven, and gastric carcinoma in two. Endoscopic findings in 10 patients were interpreted as heterotopic pancreas in two, submucosal tumor in six, and gastric carcinoma in two. In 12 patients, central umbilications suggesting a rudimentary duct of the heterotopic pancreas were identified in only three (25%) patients. In the remaining nine patients, neither radiography nor endoscopy demonstrated the presence of central umbilication in the lesions, and they were misinterpreted as submucosal tumors or as gastric carcinomas.
Preoperatively, CT depicted 11 (92%) of the 12 lesions on helical CT scans or on nonhelical CT scans. However, without prior information on the upper gastrointestinal study or endoscopic biopsy, CT findings were prospectively interpreted correctly as heterotopic pancreas, which was located along the greater curvature of the prepyloric antrum, in only two (17%) cases. The remaining 10 (83%) cases were misinterpreted as leiomyoma in four, carcinoid tumor in three, submucosal scirrhous carcinoma in two, and lymphadenopathy in one. Each patient had a single lesion. The long-axis diameter and the height of the lesions on CT scans was 1.0 x 0.85.0 x 3.7 cm (mean size, 2.7 x 1.9 cm). Nine (75%) of the 12 lesions were less than 3.0 cm. The remaining three (25%) were 3.05.0 cm. The shapes of the lesions on CT scans were oval in eight cases, round in three, and lobulated in one.
In six of the seven patients who underwent dual-phase helical CT with water as an oral contrast agent, the portal phase images depicted the submucosal location of the lesions with well-enhanced, intact, overlying mucosa (Figs 13). Of these six patients, four had lesions with homogeneous or heterogeneous enhancement similar to that of normal pancreas (Fig 3). The appearances of these six patients lesions on helical CT scans were as follows: an oval well-defined submucosal mass with smooth or serrated margins (Figs 1, 3) in four patients; an oval submucosal mass with indistinct margins (Fig 2) in one; and a large infiltrating submucosal mass in one. In one patient with a large infiltrating lesion, double-contrast upper gastrointestinal examination showed a sharply demarcated broad-based submucosal mass in the gastric antrum and body with a double-contoured, small, round area within it (Fig 4a). Helical CT scans obtained during the portal phase showed a broad-based, submucosal infiltrating mass with marked enhancement and with a small submucosal cyst at the top (Fig 4b). Microscopic examination confirmed the infiltration of the heterotopic pancreatic tissue in the submucosa into the muscle layer, which corresponded well with helical CT findings (Fig 4c). A small cystic area was a markedly dilated anomalous duct of heterotopic pancreas, which was bordered by pancreatic excretory epithelium. This small cystic area within the lesion was seen in two cases. No communication between the cystic dilatation of heterotopic pancreatic duct and the gastric lumen was found.
|
|
|
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Most often, heterotopic pancreas is found in the stomach, duodenum, or upper part of the jejunum (38). On occasion, this anomaly has been reported in the ileum, gallbladder, bile duct, spleen, umbilicus, regional papilla of the accessory pancreatic duct, omentum, mesentery, mediastinum, and Meckel diverticulum (3,57). Heterotopic pancreas in the stomach usually is 13 cm in diameter and usually is located along the greater curvature of the stomach, often in the gastric antrum within 6 cm of the pyloric canal (37). In our series, nine (75%) of the 12 cases of heterotopic pancreas were identified in this typical locationin the gastric antrum on the greater or lesser curvature. The remaining three cases of heterotopic pancreas were in atypical locationsin the body, fundus, or perigastric fat of the prepyloric antrum. Nine (75%) cases of heterotopic pancreas in our series were less than 3 cm in diameter, and the remaining three (25%) were 35 cm. The sizes and locations of the cases of heterotopic pancreas in our series were similar to those in previous reports (57).
The radiographic findings of heterotopic pancreas in the stomach at upper gastrointestinal examination have been described as a small usually round or oval mass that is sharply marginated and broad based (48). Therefore, heterotopic pancreas in the stomach may easily be misinterpreted as a gastric submucosal tumor such as leiomyoma. In our study, most of the lesions were identified at CT as oval or round masses in the gastric wall that were similar to other gastric tumors. In addition, heterotopic pancreas was difficult to differentiate from other submucosal tumors on nonhelical CT scans with positive oral contrast material.
It has been reported that water as an oral contrast agent provides adequate distention and satisfactory contrast for the depiction of subtle abnormalities in the gastric wall (11,12). For the improved depiction of gastric lesions, therefore, we performed dual-phase helical CT with water as an oral contrast agent in seven patients. On the portal phase images, we could better detect the submucosal location of heterotopic pancreas between the intraluminal water of the stomach and a well-enhanced overlying intact mucosal layer. In addition, four of these lesions had contrast enhancement similar to that of normal pancreas. Nevertheless, preoperatively, CT findings were interpreted correctly as heterotopic pancreas in two (17%) cases, and the remaining 10 (83%) cases were misinterpreted as leiomyoma in four, as carcinoid tumor in three, as submucosal scirrhous carcinoma in two, and as lymphadenopathy in one. Thus, our study results showed that it was difficult to distinguish heterotopic pancreas in the stomach from other submucosal tumors on CT scans, even though images with better contrast in the gastric wall were obtained at helical CT.
Kawamoto et al (13) reported endoscopic ultrasonographic (US) findings of five cases of heterotopic pancreas in the stomach and duodenum. In their study, cases of heterotopic pancreas appeared as submucosal masses with unclear or serrated margins, and two lesions appeared to infiltrate into the muscle layer. It is unfortunate that, to our knowledge, even endoscopic US cannot be used to confirm this diagnosis. In our study, however, four of the seven cases in which helical CT was performed with water as an oral contrast agent appeared to be well-defined submucosal masses with smooth or serrated margins, which corresponded well with the gross findings of heterotopic pancreas.
On occasion, heterotopic pancreas in the stomach appears at upper gastrointestinal study as a mass with an irregular surface that is indistinguishable from adenomatous polyp or even from polypoid carcinoma (4,7,8). In our series, two cases of heterotopic pancreas were misinterpreted as submucosal scirrhous carcinoma at CT because of the atypical locations and the highly atypical appearances of lesions that were considerably larger and more lobulated than the majority of cases of heterotopic pancreas. At helical CT, one of these two lesions had a broad-based submucosal infiltration with marked enhancement; the lesion was misinterpreted as a gastric carcinoma with submucosal infiltration. Histopathologic examination of the lesion, however, showed heterotopic pancreatic tissue in the submucosa that was infiltrating into the muscle layer; this corresponded well with the CT findings.
On rare occasions, complications, including pancreatitis, pseudocyst, cyst formation, insulinoma, adenoma, and malignant transformation, have been reported (210) in cases of gastric heterotopic pancreas. Claudon et al (9) reported that cyst formation in heterotopic pancreas in the stomach was related to cystic dilatation of an anomalous duct bordered by pancreatic excretory epithelium. In our series, a small cystic area within heterotopic pancreas on CT scans that was confirmed as a markedly dilated anomalous duct was seen in two patients. Malignant transformation of heterotopic pancreas is extremely rare, and, to our knowledge, there are only sporadic case reports available in the literature (10). In our series, one patient who underwent helical CT for the preoperative staging of gastric carcinoma had heterotopic pancreas that was detected incidentally as a nodular lesion in the perigastric fat of the prepyloric antrum. The lesion was poorly enhanced at the portal phase and was misinterpreted as lymphadenopathy. At microscopic examination, however, the nodule was shown to be heterotopic pancreas with malignant change to mucinous cystadenocarcinoma, and the lesion of the gastric antrum was an early gastric carcinoma that was confirmed as a moderately differentiated tubular adenocarcinoma. We consider that the lesion was poorly enhanced on the portal phase images because of abundant mucin content.
Heterotopic pancreas in the stomach has been described as a small asymptomatic lesion and usually is of no clinical importance (38). Therefore, if an accurate radiologic diagnosis can be made or if the lesion is asymptomatic, expectant management may be justified (3,14,15). However, it is necessary to resect heterotopic pancreas in the stomach if it causes symptoms or if a neoplastic condition cannot be excluded at radiologic or endoscopic examination (5,7,14,15). In our series, in contrast with those in previous reports, nine of the 12 patients had epigastric pain, and one had melena. Only four of these 10 patients with apparent symptoms received a diagnosis of heterotopic pancreas at endoscopic biopsy. Six patients with symptomatic lesions and one patient with an asymptomatic lesion had a failed diagnosis at endoscopic biopsy; preoperatively, seven patients lesions were misinterpreted as a submucosal tumor. The remaining patients lesion also was misinterpreted as lymphadenopathy. Therefore, all 12 patients lesions were treated with surgical resection or endoscopic excision. After treatment of the lesions, symptoms were improved in six patients who underwent follow-up evaluation.
With regard to the limitations of our study, 12 cases were selected in which CT was performed with different scanning protocolsnonhelical CT and helical CTbecause patients with heterotopic pancreas in the stomach who underwent CT were not encountered commonly. In addition, most of our subjects were selected from among clinically symptomatic patients who underwent CT because of suspected submucosal tumors. Therefore, our study included symptomatic cases with atypical appearances rather than asymptomatic cases with typical appearances of heterotopic pancreas. Thus, there was a selection bias, since smaller lesions with typical appearances and locations generally were not included in our study. Moreover, helical CT with water as an oral contrast agent was performed in only seven patients, and with the small number of cases that were depicted retrospectively, it was difficult to evaluate the usefulness of this technique for the diagnosis of heterotopic pancreas.
In conclusion, although helical CT with water as an oral contrast agent was helpful in depicting heterotopic pancreas in the stomach, the CT findings of heterotopic pancreas appeared to be nonspecific for the diagnosis, except for its location. Our results suggest that heterotopic pancreas in the stomach is difficult to differentiate from other submucosal tumors at CT. Therefore, we think that endoscopic biopsy should be performed prior to the surgical resection of heterotopic pancreas, and a more conservative approach than surgery should be considered in asymptomatic patients.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. S. Shin, Y. Y. Jeong, and H. K. Kang Giant Heterotopic Pancreas in the Jejunal Mesentery Am. J. Roentgenol., November 1, 2007; 189(5): W262 - W263. [Full Text] [PDF] |
||||
![]() |
K. Sandrasegaran, D. D. Maglinte, and O. W. Cummings Heterotopic pancreas: presentation as jejunal tumor. Am. J. Roentgenol., December 1, 2006; 187(6): W607 - W609. [Full Text] [PDF] |
||||
![]() |
J. H. Kim, H. W. Eun, D. E. Goo, C. S. Shim, and Y. H. Auh Imaging of Various Gastric Lesions with 2D MPR and CT Gastrography Performed with Multidetector CT. RadioGraphics, July 1, 2006; 26(4): 1101 - 1116. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |